Sleep Apnea Devices Market Size, Share and Trends 2024 to 2034

Sleep Apnea Devices Market Size and Growth 

The global sleep apnea devices market size accounted for USD 6.64 billion in 2024 and is predicted to reach around USD 13.18 billion by 2034, growing at a notable CAGR of 7% from 2024 to 2034.

Sleep Apnea Devices Market Key Takeaways

• North America led the market with the biggest market share of 49% in 2023.
• Asia Pacific is estimated to expand at the fastest CAGR during the forecast period.
• By Product, the therapeutic devices segment registered the maximum market share in 2023.

U.S. Sleep Apnea Devices Market Size and Growth 2024 To 2034

The U.S. sleep apnea devices market size was valued at USD 2.09 billion in 2023 and is expected to be worth around USD 4.56 billion by 2036, poised to grow at a CAGR of 7.18% from 2024 to 2034.

At present, geographically, North America conquers the global sleep apnea devices market and is projected to endure its stronghold in near future. This enormous growth is attributed to the great prevalence of sleep-disordered breathing and increasing aged population in this region. As per Sleep Zone, it was projected that about 22 million Americans undergo from moderate to severe sleep apnea, among them, about 3 to 7% of men and 2 to 5% of women were recognize to have had sleep apnea in the U.S in 2018.

Nevertheless, Asia Pacific is assessed to exhibit highest CAGR during estimate period on account of snowballing occurrence of sleep apnea illnesses in this region, and deliberate agreements of international market front-runners with local companies. Additionally, huge undiagnosed pool in nations such as India, and initiatives undertaken by the government and other private administrations to promote awareness concerning sleep disorders is projected to further push the market growth in this region.

Sleep Apnea Devices Market Growth Factors

Several influences including an enormous pool of undiagnosed patients suffering from sleep apnea, mounting utilization of oral appliances, and technological advancements in sleep apnea devices are flourishing the growth of the global sleep apnea market.

Substantial venture capital finance, cumulative number of establishments volunteering into sleep apnea and oral appliances sector is expected to upsurge the market demand during near future. Additionally, escalating pervasiveness of obstructive sleep apnea at a worldwide level is estimated to significantly push sale of sleep apnea devices during years to come.

Global sleep apnea market is expected to record optimistic growth due to several probable advantages presented by mHealth and telemedicine in improving sleep apnea management and diagnosis. Numerous studies have stated that a foremost projecting aspect for long-term CPAP compliance is patient observance in the first few weeks of treatment. In order to advance compliance, follow-up and support throughout this period must be quick. Telemedicine provides such sort of support since extended waiting lists make it problematic to deliver this support. Many studies recommend that patients in the telemedicine group conveyed high satisfaction with their care and specifically enjoyed the suitability of a live video visit with doctor and consultant.

Sleep Apnea Devices Market Scope

Product Insights

Among different product segments analyzed in this report, therapeutic devices led the market in 2023 with majority of the revenue share. This development is credited to augmented disease consciousness amid patients, obtainability of technologically enhanced products, and intensifying market competition.

Further, PAP devices sub-segment is assessed to see noteworthy growth throughout assessment period. This great growth is accredited to mounting requirement for competent, superior and transportable sleep apnea devices. Moreover, existence of satisfactory insurance coverage for management of sleep apnea and other sleep disorders would supplement demand for PAP devices worldwide. Growing commonness of sleep apnea and associated co-morbidities in numerous parts of the globe is a foremost influence heightening the importance of polysomnography devices. Furthermore, intensify ingresponsiveness for sleep apnea and other sleep disorders among the populace will further add to their market growth.

End-user Insights

Different end-use sectors assessed in this research report include diagnostic devices and therapeutic devices. The assortment of devices employed in hospitals and sleep laboratories is restricted mostly to diagnostic devices including tabletop pulse oximeters, actigraphy systems, and clinical PSG devices. There is a progression in the number of sleep tests and labs accomplished with the help of a clinical polysomnography device across the world, as these tests are being assumed the standard diagnostic test for sleep apnea since long time period.

Sleep Apnea Devices Market Companies

• GE Healthcare
• BMC Medical
• Philips Healthcare
• Weinmann Medical Devices
• CadwellLaboratorie
• Compumedics
• Curative Medical
• Teleflex
• CareFusion Corporation
• Fisher &Paykel Healthcare
• ResMed
• SOMNOmedics
• Invacare Corporation
• Natus Medical

Segments Covered in the Report

By Product Type

• Diagnostic Devices
  • Respiratory Polygraphs
  • Actigraphs
  • Polysomnography (PSG) Device
  • Pulse Oximeters
• Therapeutic Devices
  • Nasal Devices
  • Positive Airway Pressure (PAP) Devices
  • Oral Devices
  • Chin Straps

By End-User

• Home Care Setting
• Sleep Laboratories & Hospitals
• Others

By Regional Outlook

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
• Middle East & Africa
• Latin America